INFINIUM Infinium Pharmachem Ltd Investor Conferences Announcement 2025 - H1FY26 Presentation Infinium Pharmachem to present H1 FY26 unaudited results at investor meeting, highlighting EBITDA growth, revenue CAGR, and steady margins amid iodine-chemistry focus..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Infinium Pharmachem Ltd